ArticleCancers2021

Neutrophil-to-Lymphocyte Ratio Is a Predictive Biomarker in Patients with Epidermal Growth Factor Receptor (EGFR) Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) Treated with Tyrosine Kinase Inhibitor (TKI) Therapy.

Nicole K Yun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.